Skip to content

BIOTECH ENGINEERING

Active
Private limited companyfounded 1997active for 29 yearsAmelia Earhartlaan 2, 9051 Gent, Belgium72 active companies are registered at this addressKBO/BCE: BE 0460.320.725
Summary

BIOTECH ENGINEERING has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €418,727 and a net result of €242,696. Equity is shrinking by about 4.4% per year across the filed financial years. Its solvency ranks better than 49% of 11,709 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
BIOTECH ENGINEERINGActiveChecked score 97/100
Risk analysis ReportCompare

History

BIOTECH ENGINEERING was incorporated on 28 March 1997.1 The registered office was moved to Gent in 2026.2 Total assets went from €798,845 in 2019 to €787,615 in 2025 and headcount from 1.2 to 1 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 13-03-2026
  3. 3National Bank, annual accounts 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-10-2026
2026
07-04
Gazette deed Permanent representative: Van Hulle, Sam Georges Eric
Registered-office move · Amendment of the articles · Capital7 facts ▸
  • General meeting, 05-03-2026
  • Registered-office move, Vlaamse Gewest
  • Amendment of the articles
  • Capital
  • Board meeting, 05-03-2026
  • Other provision, “dagelijks bestuurder, benoeming dagelijks bestuurder” (deed in Dutch)
  • Permanent representative, Van Hulle, Sam Georges Eric
13-03
Gazette deed Resignations: Heyvaerts,Stefaan Fernand Marie, BIOTECH-INVEST and AIM
Appointment: DDE Group (director) · Permanent representative: Aelvoet,Dieter · Registered-office move11 facts ▸
  • General meeting, 05-03-2026
  • Other provision, “abbreviation addition, ajouter dans les statuts au nom de la société” (deed in French)
  • Registered-office move, Amelia Earhartlaan 2,boîte 304,9051 Gent(Sint-Denijs-Westrem)
  • Transfer restriction, “modifier les règles,adopter une nouvelle réglementation intégrée dans la nouvelle version des statuts” (deed in French)
  • Director resignation, Heyvaerts,Stefaan Fernand Marie (director)
  • Director resignation, BIOTECH-INVEST (director)
  • Director resignation, AIM (director)
  • Director appointment, DDE Group (director (not named in the articles))
  • Permanent representative, Aelvoet,Dieter
  • Other provision, “exercice social transitoire en cours”, 31-12-2026 (deed in French)
  • Amendment of the articles
2025
04-08
NBB filing Annual accounts filed
financial year 2025 · micro format
31-03
Financial Highest result from 2019 to 2025net €242,696 ▲22,835%
Operating result €317,245, net result €242,696, both a record.
2024
28-10
NBB filing Annual accounts filed
financial year 2024 · micro format
2023
12-12
Gazette deed Resignation: HEYVAERTS Stefaan Fernand Marie (manager)
Appointments: HEYVAERTS Stefaan Fernand Marie (administrateur non statutaire) and BIOTECH-INVEST (administrateur non statutaire) · Permanent representative: Lammens Kathleen · Amendment of the articles11 facts ▸
  • General meeting, 01-12-2023
  • Amendment of the articles (2 times)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Other provision, “formes et majorités de la modification des statuts, ci-inclus les apports non appelés” (deed in French)
  • Director resignation, HEYVAERTS Stefaan Fernand Marie (manager)
  • Director appointment, HEYVAERTS Stefaan Fernand Marie (administrateur non statutaire)
  • Director appointment, BIOTECH-INVEST (administrateur non statutaire)
  • Permanent representative, Lammens Kathleen
  • Registered office clause, “7522 Tournai(Marquain),Rue de la Grande Couture 2, QUATRIÈME POINT DE L’ORDRE DU JOUR” (deed in French)
  • Capital
  • Power of attorney
29-09
NBB filing Annual accounts filed
financial year 2023 · micro format
31-03
Financial Weakest financial yearnet €285 ▼99%
Net result drops to €285, the lowest in the series; recovery starts the following year.
2022
03-11
NBB filing Annual accounts filed
financial year 2022 · full format · 3 days late
2021
01-10
NBB filing Annual accounts filed
financial year 2021 · micro format
2020
03-11
NBB filing Annual accounts filed
financial year 2020 · full format · 3 days late
31-03
Financial Equity above €500,000equity €525,845 ▲7.9%
A profit in every financial year since 2019 builds equity to €525,845.
Show earlier events
2019
31-10
NBB filing Annual accounts filed
financial year 2019 · full format
2018
22-10
NBB filing Annual accounts filed
financial year 2018 · full format
2017
12-10
NBB filing Annual accounts filed
financial year 2017 · full format
2016
30-09
NBB filing Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 29 annual accounts filed, the latest 10 are here; all 29 are under Financials.
3 of 4 deeds read
About the unread acts

Of the 4 Belgian Official Gazette deeds we know for this company, 3 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure